Tweet from Bob_Wachter at December 23, 2021 at 10:57AM
In more Good News/Bad News news, yesterday’s highlights:
Good: @NEJM remdesivir study, adds 3rd option for hi-risk outpts. 3d of IV aint easy, but may help until we have enuf Sotrovimab (only MAb that works vs Omi) & especially Paxlovid (Pfizer oral).(1/3)https://t.co/jIGFMMBWSx— Bob Wachter (@Bob_Wachter)
Dec 23, 2021
from http://twitter.com/Bob_Wachter